Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
IGF-1 (Biogen/Pharmacia & Upjohn) | Approved | Biogen Inc, Pharmacia & Upjohn | Igef | Sweden | Dwarfism | null | 1994-01-01 | Dwarfism | Details | |
Mecasermin (Astellas/OrphanPacific) | Approved | Astellas Pharma Inc | Somazon | Japan | Dwarfism; Diabetes Mellitus, Lipoatrophic; Growth hormone deficiency | null | 1994-10-05 | HIV Infections; Diabetes Mellitus, Lipoatrophic; Heart Failure; Myocardial Infarction; Multiple Sclerosis; Lipodystrophy; Dwarfism; Growth hormone deficiency | Details | |
Mecasermin (Ipsen) | IGF-1; FK-780; MKN-031 | Approved | Ipsen | Increlex | EU | Laron Syndrome | Ipsen Pharma | 2005-08-30 | Failure to Thrive; Autism Spectrum Disorder; X-Linked Combined Immunodeficiency Diseases; Phelan-McDermid syndrome; Growth Disorders; Muscular Dystrophy, Duchenne; Laron Syndrome | Details |
Brigatinib | AP-26113 | Approved | Ariad, Takeda Pharmaceutical Co Ltd | Alunbrig | Mainland China | Carcinoma, Non-Small-Cell Lung | Takeda (China) International Trading Co Ltd | 2017-04-28 | Solid tumours; Ependymoma; Carcinoma; Neoplasms; Neurofibromatosis 2; Myofibroma; Lymphoma, Large-Cell, Anaplastic; Granuloma, Plasma Cell; Lung Neoplasms; Brain metastases; Carcinoma, Non-Small-Cell Lung; Sarcoma, Kaposi; Meningioma; Neurilemmoma; Neuroma, Acoustic | Details |
Teprotumumab | R-1507; RG-1507; RO-4858696; HZN-001 | Approved | Genmab A/S, F. Hoffmann-La Roche Ltd | Tepezza | United States | Graves Ophthalmopathy | Horizon Therapeutics Ireland | 2020-01-21 | Neoplasms; Graves Ophthalmopathy; Sarcoma; Breast Neoplasms; Diabetic macular oedema; Scleroderma, Diffuse; Carcinoma, Non-Small-Cell Lung | Details |
Ceritinib | LDK-378; NVP-LDK378; NVP-LDK378-NX | Approved | Novartis Pharma Ag | 赞可达, Zykadia | Mainland China | Carcinoma, Non-Small-Cell Lung | Novartis Europharm Ltd | 2014-04-29 | Hepatic Insufficiency; Melanoma; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Thyroid Neoplasms; Brain metastases; Esophageal adenocarcinoma; Granuloma, Plasma Cell; Lymphoma, Large-Cell, Anaplastic; Hematologic Neoplasms; Colorectal Neoplasms; Cholangiocarcinoma; Thyroid Carcinoma, Anaplastic; Neoplasms; Pancreatic Neoplasms; Glioblastoma; Stomach Neoplasms | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
124I-CPD-1023-figitumumab | 124I-CPD-1028; 125I-CPD-1028; CPD-1028-[124I]; CPD-1028-[125I]; FPX-1028 | Phase 1 Clinical | Fusion Pharma | Neoplasms | Details |
Insulin-Like Growth Factor 1 (Wright State Physicians) | Phase 1 Clinical | Wright State Physicians | Nasolabial fold wrinkles; Sunburn | Details | |
Lonigutamab | VB-421 | Phase 1 Clinical | Pierre Fabre Group | Graves Ophthalmopathy | Details |
IGF-1 receptor oligodeoxynucleotide-based immunotherapy (Thomas Jefferson University) | Phase 1 Clinical | Sidney Kimmel Cancer Center | Glioma | Details | |
BVS-857 | BVS-857 | Novartis Pharma Ag | Details | ||
VPI-2690B | VPI-2690B | University Of North Carolina At Chapel Hill | Details | ||
KW-2450 | KW-2450 | Kyowa Hakko Kirin Co Ltd | Details | ||
BIIB-022 | BIIB-022 | Biogen Inc | Details | ||
Mecasermin Rinfabate | OHB-607; SHP-607; HGT-ROP-001; rhIGF-I/rhIGFBP-3; TAK-607 | Phase 2 Clinical | Insmed | Noonan Syndrome; Failure to Thrive; Cerebral Intraventricular Hemorrhage; Myotonic Dystrophy; Bronchopulmonary Dysplasia; Retinopathy of Prematurity; Muscular Dystrophies; Laron Syndrome | Details |
Teprotumumab biosimilar(Innovent) | IBI-311 | Phase 1 Clinical | Innovent Biologics(Suzhou) Co Ltd | Graves Ophthalmopathy | Details |
Picropodophyllin | PPP; AXL-1717; NSC-36407 | Phase 2 Clinical | Axelar Ab | Astrocytoma; Carcinoma, Non-Small-Cell Lung | Details |
Linsitinib | OSI-906; ASP-7487; OSI-906AA | Phase 3 Clinical | Astellas Pharma Inc, National Cancer Institute | Endocrine System Diseases; Paraganglioma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Eye Diseases; Orbital Diseases; Gastrointestinal Stromal Tumors; Colorectal Neoplasms; Breast Neoplasms; Prostatic Neoplasms; Sarcoma, Ewing; Graves Ophthalmopathy; Solid tumours; Multiple Myeloma; Adrenocortical Carcinoma; Small Cell Lung Carcinoma; Pancreatic Neoplasms; Skin Neoplasms; Neoplasms; Hashimoto Disease; Carney Complex; Liver Neoplasms; Chondrosarcoma; Thyroid Diseases; Ovarian Neoplasms | Details |
Cixutumumab | A-12; IMC-A12; LY-3012217; NSC-742460 | Phase 2 Clinical | Eli Lilly And Company | Osteosarcoma; Gliosarcoma; Adenocarcinoma, Bronchiolo-Alveolar; Colorectal Neoplasms; Medullary thyroid cancer (MTC); Neuroblastoma; Gastrinoma; Neurofibrosarcoma; Retinoblastoma; Brain Stem Neoplasms; Breast Neoplasms; Prostatic Neoplasms; Sarcoma; Sarcoma, Ewing; Lymphoma, Mantle-Cell; Liposarcoma; Glucagonoma; Esophageal adenocarcinoma; Neuroectodermal Tumors, Primitive, Peripheral; Adenocarcinoma; Paraganglioma; Melanoma; Breast Neoplasms, Male; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Sarcoma, Alveolar Soft Part; Adrenocortical Carcinoma; Glioma; Rhabdomyosarcoma, Alveolar; Esophageal Squamous Cell Carcinoma; Hemangiopericytoma; Carcinoma, Neuroendocrine; Lung Neoplasms; Pinealoma; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Merkel Cell; Insulinoma; Hemangiosarcoma; Mesenchymoma; Hepatoblastoma; Stomach Neoplasms; Esophageal Neoplasms; Carcinoma; Desmoplastic Small Round Cell Tumor; Kidney Neoplasms; Fibrosarcoma; Chondrosarcoma; Liver Neoplasms; Head and Neck Neoplasms; Leiomy | Details |
Ganitumab | AMG-479 | Phase 3 Clinical | Amgen Inc | Prostatic Neoplasms; Neuroectodermal Tumors, Primitive, Peripheral; Gastrointestinal Neoplasms; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Rhabdomyosarcoma, Alveolar; Lymphoma; Lung Neoplasms; Neuroectodermal Tumors, Primitive; Colorectal Neoplasms; Sarcoma, Ewing; Breast Neoplasms; Sarcoma; Solid tumours; Pancreatic Neoplasms; Colonic Neoplasms; Small Cell Lung Carcinoma; Neoplasms; Rhabdomyosarcoma, Embryonal; Rectal Neoplasms; Carcinoid Tumor; Ovarian Neoplasms; Rhabdomyosarcoma; Bone metastases; Intestinal Neoplasms | Details |
Humanized IgG1κ monoclonal antibody(Viridian) | ZB-001; AVE-1642; VRDN-001 | Phase 2 Clinical | Viridian Therapeutics Inc | Solid tumours; Multiple Myeloma; Graves Ophthalmopathy; Breast Neoplasms | Details |
FPI-1434 | [225Ac]-FPI-1434; FPX-01 | Phase 2 Clinical | Fusion Pharma | Ovarian Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Neoplasms; Uveal melanoma; Adrenocortical Carcinoma; Breast Neoplasms; Endometrial Neoplasms; Uterine Cervical Neoplasms | Details |
PHP-1003 | PHP-1003; PHP1003 | Phase 1 Clinical | Graves Ophthalmopathy | Details | |
lonigutamab ugodotin | W-0101 | Phase 2 Clinical | Pierre Fabre Group | Solid tumours | Details |
Conteltinib | CT-707; SY-707 | Phase 3 Clinical | Shouyao Holding (Beijing) Co Ltd, Centaurus Biopharma Co Ltd | Pancreatic Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
VRDN-002 | VRDN-002 | Phase 1 Clinical | Viridian Therapeutics Inc | Graves Ophthalmopathy | Details |
CT-102 | CT-102 | Phase 2 Clinical | Hangzhou Tianlong Pharmaceutical Co Ltd, Institute Of Radiation And Radiation Medicine, Chinese Academy Of Military Medical Sciences | Liver Neoplasms; Carcinoma, Hepatocellular | Details |
This web search service is supported by Google Inc.